Cargando…
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
BACKGROUND: Zoledronic acid is the most potent osteoclast inhibitor and is widely used for advanced cancer patients with bone metastasis, but its role on cancer stem cells (CSCs) remains unclear. In the present study, we aimed to identify the stemness phenotypic characteristics of CSCs derived from...
Autores principales: | Wang, Li, Liu, Yanyang, Zhou, Yueling, Wang, Jiantao, Tu, Li, Sun, Zhen, Wang, Xiujie, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385443/ https://www.ncbi.nlm.nih.gov/pubmed/30791957 http://dx.doi.org/10.1186/s13046-019-1109-z |
Ejemplares similares
-
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
por: Wang, Yuyi, et al.
Publicado: (2018) -
Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function
por: Misra, Juhi, et al.
Publicado: (2015) -
Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma
por: Kim, Kwang Woon, et al.
Publicado: (2019) -
Gomisin G Suppresses the Growth of Colon Cancer Cells by Attenuation of AKT Phosphorylation and Arrest of Cell Cycle Progression
por: Maharjan, Sony, et al.
Publicado: (2019) -
Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways
por: Li, Liu, et al.
Publicado: (2018)